Literature DB >> 23254817

The future of robotics in radiosurgery.

John R Adler1.   

Abstract

After emerging from and transforming the practice of neurosurgery, stereotactic radiosurgery is increasingly affecting all surgical disciplines. The first generation of frame-based devices limited radiosurgery treatment to lesions of the brain where the rigidity of the skull provided adequate skeletal purchase. In an effort to surmount such anatomic limitations, robotic radiosurgery was developed. After almost 2 decades of existence, the technology and clinical application of image-guided robotic radiosurgery have evolved considerably, and today a range of treatments with such technology have become commonplace. Nevertheless, the timeless allure of a truly noninvasive, yet highly effective, therapy promises that further refinements in robotic radiosurgery will be forthcoming well into the future.

Entities:  

Mesh:

Year:  2013        PMID: 23254817     DOI: 10.1227/NEU.0b013e318271ff20

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

Review 1.  Current state-of-the-art and future perspectives of robotic technology in neurosurgery.

Authors:  Tobias A Mattei; Abraham Hafiz Rodriguez; Deepak Sambhara; Ehud Mendel
Journal:  Neurosurg Rev       Date:  2014-04-13       Impact factor: 3.042

Review 2.  Stereotactic modulation of blood-brain barrier permeability to enhance drug delivery.

Authors:  Geoff Appelboom; Alexandre Detappe; Melissa LoPresti; Sijumon Kunjachan; Stefan Mitrasinovic; Serge Goldman; Steve D Chang; Olivier Tillement
Journal:  Neuro Oncol       Date:  2016-07-11       Impact factor: 12.300

3.  Rat sensorimotor cortex tolerance to parallel transections induced by synchrotron-generated X-ray microbeams.

Authors:  Erminia Fardone; Alberto Bravin; Alfredo Conti; Elke Bräuer-Krisch; Herwig Requardt; Domenico Bucci; Geraldine Le Duc; Giuseppe Battaglia; Pantaleo Romanelli
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.